Due to the effects of Cobll1 on drug sensitivity in CML, we further validated the function of PACSIN2 on nilotinib resistance by evaluating the apoptotic index using fluorescence‐activated cell sorting (FACS) analysis (Figure S3). The gene discussed is PACSIN2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.